It is believed that CD36 polymorphisms confer susceptibility for hypertension and/or CAD due to the roles of CD36 in the regulation of lipid metabolism, atherosclerosis, and blood pressure [12, 15, 16]. This evidence concerns the gene CD36 and coronary artery disorder.